Medications for Kidney Stones

Acute Pain Management

The European Association of Urology recommends NSAIDs (diclofenac, ibuprofen, or metamizole) as the first-line medication for acute renal colic, providing superior pain relief compared to opioids while reducing the need for additional analgesia 1
The European Association of Urology suggests using NSAIDs at the lowest effective dose due to potential cardiovascular and gastrointestinal risks, and may impact renal function in patients with reduced glomerular filtration rate 1
Opioids (hydromorphine, pentazocine, or tramadol—but NOT pethidine) are reserved as second-choice analgesics when NSAIDs are contraindicated or ineffective, according to the European Urology guidelines 1

The American Urological Association strongly recommends alpha-blockers (tamsulosin) for conservative management of ureteral stones, particularly those >5 mm in the distal ureter 1
The American Urological Association suggests that MET is appropriate for uncomplicated ureteral stones up to 10 mm 2
The maximum duration of conservative treatment should be 4-6 weeks from initial presentation, as recommended by the American Urological Association 2

The American Urological Association recommends thiazide diuretics combined with dietary sodium restriction (≤2,300 mg/day) as first-line prevention for calcium stones with hypercalciuria 3
Thiazide diuretics lower urinary calcium excretion and should be continued with sodium restriction to maximize the hypocalciuric effect, according to the American Urological Association 3
Potassium citrate therapy is recommended for calcium stones with hypocitraturia, as it is a potent inhibitor of calcium phosphate crystallization 3

The American Urological Association recommends potassium citrate as first-line therapy for uric acid stones, with a target urinary pH of approximately 6.0 3
Most patients with uric acid stones have low urinary pH rather than hyperuricosuria, making urinary alkalinization more important than allopurinol, according to the American Urological Association 3
Oral chemolysis with citrate or sodium bicarbonate (pH 7.0-7.2) can dissolve existing uric acid stones, with an 80.5% success rate, as reported in the European Urology journal 1

The American Urological Association recommends potassium citrate to raise urinary pH to approximately 7.0, combined with increased fluid intake (≥4 liters/day) for cystine stones 3
Cystine-binding thiol drugs such as tiopronin should be offered to patients unresponsive to dietary modifications and urinary alkalinization, according to the American Urological Association 4

The American Urological Association suggests that acetohydroxamic acid (AHA) may be considered as a urease inhibitor in high-risk patients or when surgery is not feasible, though extensive side effects may limit use 3
Complete surgical removal coupled with appropriate antibiotic therapy is necessary for definitive treatment, as recommended by the European Urology guidelines 1

The American Urological Association recommends potassium citrate as first-line therapy for calcium phosphate or brushite stones with hypocitraturia, but exercise caution with excessive alkalinization 3
Thiazide diuretics should be offered to brushite stone formers with hypercalciuria, as they may increase the safety and efficacy of citrate therapy, according to the American Urological Association 2

The American Urological Association recommends that all patients increase fluid intake to achieve urine volume of at least 2.5 liters daily 3
For cystine stones specifically, target at least 4 liters per day to decrease urinary cystine concentration below 250 mg/L, as recommended by the American Urological Association 4

The American Urological Association recommends obtaining a 24-hour urine specimen within 6 months of initiating treatment to assess response to therapy 3
Continue annual 24-hour urine collections for ongoing monitoring, with more frequent testing depending on stone activity, according to the American Urological Association 4
Perform periodic blood testing to monitor for adverse effects: hypokalemia with thiazides and hyperkalemia with potassium citrate, as recommended by the American Urological Association 3

Do not prescribe allopurinol as first-line therapy for uric acid stones without first addressing urinary pH with potassium citrate, according to the American Urological Association 3
Do not use sodium citrate instead of potassium citrate, as the sodium load increases urinary calcium excretion, as recommended by the American Urological Association 3
Do not neglect monitoring for medication side effects, particularly electrolyte abnormalities, according to the American Urological Association 3

The American Urological Association recommends serum chemistries, including electrolytes, calcium, creatinine, bicarbonate, and uric acid, for diagnostic evaluation of brushite kidney stone formers 5, 6
Maintaining adequate dietary calcium intake, 1,000-1,200 mg/day from food sources, not supplements, is recommended for brushite kidney stone formers 5, 6
Thiazide diuretics are the cornerstone of treatment for brushite stone formers with hypercalciuria, and monitoring serum potassium within 1-2 months is necessary to prevent hypokalemia 7
Repeat stone analysis is recommended if available, especially in non-responders, as stone composition can change 7
Annual 24-hour urine collections are recommended to assess urinary calcium, phosphate, pH, and treatment response, with more frequent monitoring if stone activity persists 7